[1] LI X S, DEITELZWEIG S, KESHISHIAN A, et al. Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in "real-world" clinical practice[J].Thromb Haemost,2017,117(6):1072-1082.
[2] 何长健,张艳,马建帅,等. 中性粒细胞/淋巴细胞比值与非瓣膜性心房颤动患者左心耳血栓状态的相关性[J].中国循环杂志,2021,36(9):891-896.
[3] 韩卫全,熊洁. 非瓣膜性心房颤动患者血清尿酸、超敏C反应蛋白及同型半胱氨酸水平的检测意义及其与血栓栓塞事件的关系研究[J].血栓与止血学,2016,22(3):264-269.
[4] HU X F, ZHAN R, XU S, et al. Growth differentiation factor 15 is associated with left atrial/left atrial appendage thrombus in patients with nonvalvular atrial fibrillation[J].Clin Cardiol,2018,41(1):34-38.
[5] WANG F, ZHU M, WANG X, et al. Predictive value of left atrial appendage lobes on left atrial thrombus or spontaneous echo contrast in patients with non-valvular atrial fibrillation[J].BMC Cardiovasc Disord,2018,18(1):153.
[6] 孙志军,邓婷,彭晖. 非瓣膜性心房颤动患者血栓形成相关危险因素的评价[J].心肺血管病杂志,2019,38(7):716-735.
[7] KAWABATA M. Left atrial appendage thrombi formation in japanese non-valvular atrial fibrillation patients during anticoagulation therapy-warfarin vs. direct oral anticoagulants[J].Circ J,2017,81(5):645-651.
[8] 罗志峰.非瓣膜性心房颤动患者C反应蛋白与左心房自发显影的关系[J].中华心血管病杂志,2020,48(3):223-227.
[9] 张伯玮,张珠博,任静,等. vW因子联合D-二聚体预测非瓣膜性心房颤动患者抗凝治疗后发生血栓风险的研究[J].中华检验医学杂志,2020,43(10):1014-1020.
[10] 陈炳伟,任静,朱延波,等. 炎症与非瓣膜性心房颤动患者左心耳血栓相关性研究[J].中国心脏起搏与心电生理杂志,2019,33(1):32-34.
[11] 李晓红,胡亚民,刘丽娜,等. 心房颤动患者血清炎症指标的意义及其对合并左心耳血栓形成的预测价值[J].中国中西医结合急救杂志,2018,25(3):278-282.
[12] 宋雅文.非瓣膜性心房颤动病人CHA2DS2-VASc评分与血NT-proBNP、D-二聚体、尿酸、肌酐的相关性分析[J].中西医结合心脑血管病杂志,2020,18(8):1194-1197.
2022, Vol. 39 
